SEC Form 4 · accession 0001556244-17-000025
AdvanSource Biomaterials Corp · ASNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William J Oneill Jr.
Director
Period of report
Aug 17, 2017
Accepted (ET)
Aug 21, 2017 · 12:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001011060
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualifed Equity OptionF1 | $0.06 | Aug 17, 2017 | A | 750,000 | A | Aug 17, 2017 | Aug 16, 2027 | Common stock | 750,000 | 925,000 | D |
Explanation of responses
- F1Stock options granted on August 17, 2017 pursuant to the Company's 2017 Non-Qualified Equity Incentive Plan which are immediately exercisable into 750,000 shares of the Company's common stock at an exercise price of $0.06 per share.